Bio-Rad Laboratories, Inc. Class B
BIO.B
Key stats
- Previous close
- 389.98
- Volume
- 0
- 52-week high
- 389.98
- 52-week low
- 244.54
- Market cap
- 10.49B
- Shares out
- 5.06M
- Employees
- 7,450
- Listed
- 1900
About Bio-Rad Laboratories, Inc. Class B
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
LABORATORY ANALYTICAL INSTRUMENTS · HERCULES, CA · bio-rad.com
Quarterly results
Massive · Nov 4, 2026| Q3 2026 to Sep 30, 2026 | Q2 2026 to Jun 30, 2026 | Q1 2026 to Mar 31, 2026 | Q4 2025 to Dec 31, 2025 | |
|---|---|---|---|---|
| Revenue | $656.40M | $651.00M | $592.10M | $693.20M |
| Gross profit | $328.60M | $345.80M | $309.40M | $345.20M |
| Operating income | −$49.70M | $72.60M | $34.10M | $53.90M |
| Net income | $458.60M | $371.40M | −$527.10M | $720.00M |
| Diluted EPS | 17.02 | 13.85 | -19.55 | 26.65 |
| Operating cash flow | $96.40M | $98.70M | $108.10M | $164.90M |
| Assets | $10.78B | $10.25B | $9.79B | $10.58B |
| Liabilities | $3.18B | $3.08B | $2.94B | $3.12B |
| Equity | $7.60B | $7.17B | $6.85B | $7.45B |
Technicals
Massive · Nov 9, 2026- 50-day average368.01
- 200-day average313.11
- RSI (14 days)98.6
Short interest
Massive · Sep 30, 2026- Sep 30, 20261 shares · 1.0 days to cover
- Aug 14, 20262 shares · 1.0 days to cover
- Jul 31, 20262 shares · 1.0 days to cover
- Jul 15, 202631 shares · 1.0 days to cover
News coverage
No stories about Bio-Rad Laboratories, Inc. Class B right now.